On the public citation graph
The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control analysis from the EUGEI study.
0 signed · 51 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archpsyc.1991.01810320088015openalex-snapshot
A Polydiagnostic Application of Operational Criteria in Studies of Psychotic Illness
inferredcites →https://doi.org/10.1001/jamapsychiatry.2017.3554openalex-snapshot
Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study
inferredcites →https://doi.org/10.1002/dta.1690openalex-snapshot
Cannabis potency in the Venice area (Italy): Update 2013
inferredcites →https://doi.org/10.1002/dta.2368openalex-snapshot
Potency of Δ 9 –tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology
inferredcites →https://doi.org/10.1002/wps.20629openalex-snapshot
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
inferredcites →https://doi.org/10.1007/s11419-008-0046-xopenalex-snapshot
Cannabinoid contents in cannabis products seized in São Paulo, Brazil, 2006–2007
inferredcites →https://doi.org/10.1016/j.addbeh.2004.09.007openalex-snapshot
Illicit drug use and abuse/dependence: modeling of two-stage variables using the CCC approach
inferredcites →https://doi.org/10.1016/j.biopsych.2015.08.001openalex-snapshot
Association Between Cannabis and Psychosis: Epidemiologic Evidence
inferredcites →https://doi.org/10.1016/j.biopsych.2016.06.028openalex-snapshot
An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis
inferredcites →https://doi.org/10.1016/j.drugalcdep.2015.01.016openalex-snapshot
A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men
inferredcites →https://doi.org/10.1016/j.euroneuro.2018.07.008openalex-snapshot
GENOME-WIDE ASSOCIATION STUDY IMPLICATES CHRNA2 IN CANNABIS USE DISORDER
inferredcites →https://doi.org/10.1016/j.neuropharm.2017.06.018openalex-snapshot
Cannabis-associated psychosis: Neural substrate and clinical impact
inferredcites →https://doi.org/10.1016/j.psychres.2017.07.070openalex-snapshot
Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study
inferredcites →https://doi.org/10.1016/s0084-3970(08)70423-7openalex-snapshot
Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients: A Systematic Review
inferredcites →https://doi.org/10.1016/s2215-0366(14)00117-5openalex-snapshot
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
inferredcites →https://doi.org/10.1016/s2215-0366(19)30048-3openalex-snapshot
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
inferredcites →https://doi.org/10.1017/s0033291716003172openalex-snapshot
Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study
inferredcites →https://doi.org/10.1017/s0033291718002131openalex-snapshot
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study
inferredcites →https://doi.org/10.1017/s003329171800226xopenalex-snapshot
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
inferredcites →https://doi.org/10.1038/mp.2014.51openalex-snapshot
Genetic predisposition to schizophrenia associated with increased use of cannabis
inferredcites →https://doi.org/10.1038/mp.2016.252openalex-snapshot
Cannabis use and risk of schizophrenia: a Mendelian randomization study
inferredcites →https://doi.org/10.1038/nature13595openalex-snapshot
Biological insights from 108 schizophrenia-associated genetic loci
inferredcites →https://doi.org/10.1038/s41593-018-0206-1openalex-snapshot
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability
inferredcites →https://doi.org/10.1038/s41593-019-0416-1openalex-snapshot
Genome-wide association study implicates CHRNA2 in cannabis use disorder
inferredcites →https://doi.org/10.1093/schbul/sbi027openalex-snapshot
The Environment and Schizophrenia: The Role of Cannabis Use
inferredcites →https://doi.org/10.1093/schbul/sbw003openalex-snapshot
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
inferredcites →https://doi.org/10.1111/add.12634openalex-snapshot
Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
inferredcites →https://doi.org/10.1111/add.13082openalex-snapshot
Potency trends of Δ9‐tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005–15
inferredcites →https://doi.org/10.1111/add.13428openalex-snapshot
Evaluating the public health impacts of legalizing recreational cannabis use in the United States
inferredcites →https://doi.org/10.1111/add.13645openalex-snapshot
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people
inferredcites →https://doi.org/10.1111/add.14525openalex-snapshot
Increasing potency and price of cannabis in Europe, 2006–16
inferredcites →https://doi.org/10.1111/j.1360-0443.2006.01399.xopenalex-snapshot
The genetic epidemiology of cannabis use, abuse and dependence
inferredcites →https://doi.org/10.1111/j.1360-0443.2009.02831.xopenalex-snapshot
Genetic and environmental influences on cannabis use initiation and problematic use: a meta‐analysis of twin studies
inferredcites →https://doi.org/10.1111/j.1556-4029.2007.00603.xopenalex-snapshot
Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology*
inferredcites →https://doi.org/10.1176/appi.ajp.2019.18101217openalex-snapshot
Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample
inferredcites →https://doi.org/10.1186/s13073-017-0489-yopenalex-snapshot
Prospects for using risk scores in polygenic medicine
inferredcites →https://doi.org/10.1302/2046-3758.49.2000571openalex-snapshot
Interpreting regression models in clinical outcome studies
inferredcites →https://doi.org/10.3389/fgene.2016.00149openalex-snapshot
Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1007/978-3-031-87990-6_18openalex-snapshot
Does Cannabis Use Increase Risk of Psychotic Disorders? A Critical Examination of Causality and Differential Vulnerability
inferred← citeshttps://doi.org/10.1016/j.psychres.2024.116091openalex-snapshot
Prediction of suicidal thoughts and behaviors based on the diurnal cortisol pattern and THC dosage in continued cannabis users, a 5 year population-based matched cohort study
inferred← citeshttps://doi.org/10.1016/j.schres.2020.12.012openalex-snapshot
Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalization
inferred← citeshttps://doi.org/10.1016/j.schres.2023.02.024openalex-snapshot
Systematic review and meta-analysis on predictors of prognosis in patients with schizophrenia spectrum disorders: An overview of current evidence and a call for prospective research and open access to datasets
inferred← citeshttps://doi.org/10.1017/ipm.2021.33openalex-snapshot
From heavy cannabis use to psychosis: is it time to take action?
inferred← citeshttps://doi.org/10.1017/s0033291722002756openalex-snapshot
Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis
inferred← citeshttps://doi.org/10.1017/s2045796022000464openalex-snapshot
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study
inferred← citeshttps://doi.org/10.1080/15622975.2022.2038797openalex-snapshot
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
inferred← citeshttps://doi.org/10.1097/j.pain.0000000000001963openalex-snapshot
Adverse effects of heavy cannabis use: even plants can harm the brain
inferred← citeshttps://doi.org/10.54108/10029openalex-snapshot
Sustratos genéticos de la psicosis asociada al cannabis
inferred← citeshttps://doi.org/10.54108/10030openalex-snapshot
Genetic substrates of cannabis-associated psychosis
inferred← citeshttps://doi.org/10.70675/eacfae2az9be5z40e7zab3fz1a4a2b1e259dopenalex-snapshot
Épidémiologie analytique du continuum psychotique : une contribution à l’étude de l’étiologie des troubles psychotiques
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.